Fenaxon is a product recommended for conditions of the peripheral nervous system with direct action on the source of the problem. These include discopathy, sciatica, lumbago, carpal tunnel syndrome, plexitis, polyneuropathies, etc.   

Fenaxon contains an optimal combination of active ingredients that act on the source of the problem in acute and chronic conditions of the peripheral nervous system. It has an active therapeutic, restorative, and prophylactic effect. It reduces discomfort and participates in the regeneration of damaged nerve cells.  

Curcumin is a natural polyphenol with a strong anti-inflammatory effect. It acts directly on the focus of inflammation and has a relieving effect.[4] 

Uridine Monophosphate helps to repair damaged nerve cells and contributes to better transmission of nerve impulses.   

Acetyl-L-Carnitine has beneficial effects in chronic discomfort. 

Magnesium reduces complaints such as tingling and numbness.[5] 

B Group Vitamins and Vitamin D strengthen overall peripheral nervous system function.[6] 

* RI – reference intakes
** Unestablished Reference Intakes

[1] Negrão L, Nunes P; Portuguese Group for the Study of Peripheral Neuropathy. Uridine monophosphate, folic acid and vitamin B12 in patients with symptomatic peripheral entrapment neuropathies. Pain Manag. 2016;6(1):25-9. doi: 10.2217/pmt.15.60. Epub 2015 De

[2] Sima AA, Calvani M, Mehra M, Amato A; Acetyl-L-Carnitine Study Group. Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials. Dia

[3] Rajakrishnan V, Viswanathan P, Rajasekharan KN, Menon VP. Neuroprotective role of curcumin from curcuma longa on ethanol-induced brain damage. Phytother Res. 1999 Nov;13(7):571-4. doi: 10.1002/(sici)1099-1573(199911)13:7<571::aid-ptr494>3.0.co;2-7. PMID:

[4] Connolly GP, Duley JA. Uridine and its nucleotides: biological actions, therapeutic potentials. Trends Pharmacol Sci. 1999 May;20(5):218-25. doi: 10.1016/s0165-6147(99)01298-5. PMID: 10354618.

[5] Yousef AA, Al-deeb AE. A double-blinded randomised controlled study of the value of sequential intravenous and oral magnesium therapy in patients with chronic low back pain with a neuropathic component. Anaesthesia. 2013 Mar;68(3):260-6. doi: 10.1111/anae

[6] Manole A, Jaunmuktane Z, Hargreaves I, Ludtmann MHR, Salpietro V, Bello OD, Pope S, Pandraud A, Horga A, Scalco RS, Li A, Ashokkumar B, Lourenço CM, Heales S, Horvath R, Chinnery PF, Toro C, Singleton AB, Jacques TS, Abramov AY, Muntoni F, Hanna MG, Reill